Acute Effects of the Prostaglandin (Alprostadil) on Cerebral and Pulmonary Flow (Alprostadil)
The Acute Effects of the Prostaglandin (Alprostadil) on Cerebral and Pulmonary Flow After the Bidirectional Cavopulmonary Connection
Sponsor: The Hospital for Sick Children
Terminated
Covid 19 and difficulty with recruitment
Other terminated trials from The Hospital for Sick Children
Other Congenital Heart Disease trials with similar outcome
Listed as NCT04054115, this PHASE1 trial focuses on Congenital Heart Disease and remains terminated or withdrawn. Sponsored by The Hospital for Sick Children, it has been updated 7 times since 2019, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1
-
Mar 2023 — Jul 2024 [monthly]
Terminated PHASE1
-
Dec 2022 — Mar 2023 [monthly]
Terminated PHASE1
Status: Recruiting → Terminated
-
Oct 2021 — Dec 2022 [monthly]
Recruiting PHASE1
▶ Show 2 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Recruiting PHASE1
-
Sep 2019 — Jan 2021 [monthly]
Recruiting PHASE1
First recorded
Jul 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- The Hospital for Sick Children
For direct contact, visit the study record on ClinicalTrials.gov .